The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
6 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,279,045 in first-year total cost, median $205,975.
Most frequent study sections
- Cancer Genetics Study Section[CG]3
- Molecular Oncogenesis Study Section[MONC]1
- Special Emphasis Panel[ZRG1 MCT2-C (01)]1
- Special Emphasis Panel[ZRG1 OTC-M (08)]1
Most frequent institutions
- GEORGE WASHINGTON UNIVERSITY1
- MEDICAL UNIVERSITY OF SOUTH CAROLINA1
- NEW YORK UNIVERSITY SCHOOL OF MEDICINE1
- SAN RAFFAELE HOSPITAL1
- SUNNYBAY BIOTECH1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2020 | Regulation of human endogenous retroviruses in the context of cancer immunotherapy1R21CA249378-01 | GABELLINI, DAVIDE | SAN RAFFAELE HOSPITAL | $277,695 | ZRG1 |
| 2020 | Brca1-Mediated Suppression Of Retrotransposon Activity - Resubmission - 11R21CA235521-01A1 | BOEKE, JEF D | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | $237,724 | CG |
| 2020 | PIWI - Transposon regulation by epithelial adherens junctions1R21CA246233-01A1 | KOURTIDIS, ANTONIS | MEDICAL UNIVERSITY OF SOUTH CAROLINA, SC | $209,674 | MONC |
| 2019 | HERV-K blockade to prevent RAS activation in breast cancer1R21CA238636-01 | JOHANNING, GARY LEE | SUNNYBAY BIOTECH, CA | $160,633 | ZRG1 |
| 2018 | Role of human endogenous retroviruses in tumor immunity of ovarian carcinoma1R21CA227259-01 | CHIAPPINELLI, KATHERINE BSTRICK, REINER | GEORGE WASHINGTON UNIVERSITY, DC | $191,044 | CG |
| 2017 | Identification of Host Factors Governing Alu Retrotransposition in Human Cancer Cell Lines1R21CA219300-01 | MORAN, JOHN V. | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $202,275 | CG |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.